Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma

Archives of Medical Research
Richard E Kast, Marc-Eric Halatsch

Abstract

Given the poor prognosis of glioblastoma, we have been investigating treatments adjunctive to the current standard of resection, irradiation and temozolomide. Our focus has been on exploring already-marketed medicines that have evidence of inhibiting growth factors previously identified as active and important in glioblastoma. In this short note we describe how previous research has demonstrated that the common angiotensin-converting enzyme (ACE) inhibitor captopril used to treat hypertension and for renal protection inhibits 72-kDa matrix metalloproteinase-2 and 92-kDa matrix metalloproteinase-9, which a separate body of research shows are used by glioblastoma cells to grow and invade. We review these bodies of data and combine them to conclude that captopril may slow glioblastoma progression. Two other drugs, the aldehyde dehydrogenase inhibitor disulfiram used to treat alcoholism and the anti-HIV protease inhibitor nelfinavir also have a database supporting their incidental inhibition of matrix metalloproteinases. Given the importance of matrix metalloproteinases in helping glioblastomas grow and invade, we suggest that this trio-captopril, disulfiram, and nelfinavir-be tested for antiglioblastoma activity.

References

Dec 1, 1993·Kidney International·D SorbiL Arbeit
Jan 1, 1996·Clinical & Experimental Metastasis·J S RaoR E Sawaya
Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G H VinceJ C Tonn
Apr 17, 2001·Neuro-oncology·S A RaithathaP A Forsyth
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Mitsutoshi NakadaJunkoh Yamashita
Aug 15, 2003·International Journal of Cancer. Journal International Du Cancer·Carine MunautManuel Deprez
Oct 24, 2003·Molecular Pharmacology·Shine-Gwo ShianCheng-Wen Wu
Feb 6, 2004·Brain Tumor Pathology·Katsuzo KunishioSeigo Nagao
Feb 9, 2005·Brain Tumor Pathology·Kyoko KomatsuMakio Kobayashi
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adília HormigoEric C Holland
Dec 1, 2007·Journal of Biochemistry and Molecular Biology·Hyun-Ji ChoYoung-Chae Chang
Mar 22, 2008·Biochemical and Biophysical Research Communications·Yunge ZhaoIsa M Hussaini
May 29, 2008·Molecular Cancer Research : MCR·Emily C Brantley, Etty N Benveniste
Oct 14, 2009·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Wei ZhangTao Jiang
Dec 1, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nao InoueMizuo Miyazaki
May 27, 2010·Molecular Cancer Therapeutics·Markus D SiegelinDario C Altieri
May 4, 2011·Basic & Clinical Pharmacology & Toxicology·Eva EfsenJørn Brynskov
Jul 26, 2011·Annals of Neurology·Matthias PreusserRoger Stupp

❮ Previous
Next ❯

Citations

May 27, 2015·Toxins·Rosi BissingerFlorian Lang
May 7, 2015·Pharmacology & Therapeutics·Constantinos Alifieris, Dimitrios T Trafalis
Jun 19, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Annelise LetourneurSamuel Valable
Mar 25, 2014·Biochemical and Biophysical Research Communications·Lincan DuanYunchao Huang
Nov 1, 2016·Journal of Neurochemistry·Behnam VafadariLeszek Kaczmarek
Mar 14, 2018·Bioinformatics·Azam PeyvandipourSorin Draghici
Feb 22, 2018·Glia·Valéria Pereira FerrerRolf Mentlein
May 31, 2020·Glycobiology·Matías A PibuelSilvia E Hajos
Sep 29, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria Sofia BasileDanijela Maksimovic-Ivanic
Mar 24, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xueqing LunDonna L Senger
Nov 25, 2020·Cancers·Mahbuba R Subeha, Carlos M Telleria
Mar 22, 2021·The Journal of Biological Chemistry·Matías Arturo PibuelSilvina Laura Lompardía
Oct 1, 2013·Journal of Medicinal Chemistry·Joshua A Day, Seth M Cohen
Oct 11, 2021·Cell Death Discovery·Matías Arturo PibuelSilvina Laura Lompardía

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.